Parkridge Medical Center

Chattanooga, Tennessee 37404

1 studies enrolling now · 9 studies all time

What they study most

Abdominal (ABD) Infection, Ductal Carcinoma in Situ, Healthcare Associated Infections, Invasive Ductal Carcinoma, Lumbar Spinal Stenosis, Methicillin Resistant Staphylococcus Aureus, Methicillin-resistant Staphylococcus Aureus, Multi Drug Resistant Organisms, Ovarian Neoplasms, PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC, Skin and Soft Tissue (SST) Infection, Staphylococcus Aureus

Studies at this site

• MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study — Recruiting now
• Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) — Running, not enrolling
• INSPIRE Trial for Skin and Soft Tissue Infections — Completed
• INSPIRE Trial for Abdominal Infections — Completed
• Mupirocin-Iodophor ICU Decolonization Swap Out Trial — Completed
• Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System® — Running, not enrolling
• Active Bathing to Eliminate Infection (ABATE Infection) Trial — Completed
• Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs) — Completed
• TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer — Completed